TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

10742	Companies
230462	Keywords
158886	Articles
122432	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 05/22/2025 at 17:45, 1 year 1 month ago

Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Transgene to present 24-month disease-free survival data from all patients in Phase I part of trial of individualized cancer vaccine, TG4050, at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Disease-free Survival
BRIEF

published on 04/10/2025 at 20:20, 1 year 3 months ago

Transgene makes available the 2024 Universal Registration Document

AMF Social Responsibility Immunotherapy Registration Document Transgene
PRESS RELEASE

published on 04/10/2025 at 20:15, 1 year 3 months ago

Availability of Transgene’s 2024 Universal Registration Document (URD)
Transgene announces availability of its 2024 Universal Registration Document (URD) containing financial reports and ESG factors. French & English versions can be accessed online

Financial Reports Transgene ESG Factors 2024 Universal Registration Document French Version
BRIEF

published on 03/27/2025 at 17:50, 1 year 3 months ago

Transgene: major advances and outlook for 2025

Immunotherapy Head And Neck Cancer 2024 Financial Results TG4050 Vaccine Myvac® Platform
PRESS RELEASE

published on 03/27/2025 at 17:45, 1 year 3 months ago

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ? Strong Outlook for 2025
Transgene achieves key milestones in 2024, including clinical proof of principle for individualized cancer vaccine TG4050, with strong outlook for 2025. New trial planned in Q4 2025 for a second indication

Milestones Cancer Vaccine Transgene 2025 Outlook Clinical Proof
BRIEF

published on 01/21/2025 at 17:50, 1 year 5 months ago

Transgene Prepares for Biomed Investor Forum

Investors BIOMED Forum Immunotherapy Transgene Viral Vectors
PRESS RELEASE

published on 01/21/2025 at 17:45, 1 year 5 months ago

Transgene to Participate in the Biomed Forum Investor Conference
Transgene's management team to participate in the Biomed Forum Investor Conference in Paris on February 4, 2025

Investor Conference Paris BIOMED Forum Transgene February 4
BRIEF

published on 11/05/2024 at 07:35, 1 year 8 months ago

Transgene and ProBioGen join forces for personalized cancer vaccines

Biotechnology Cancer Transgene ProBioGen Personalized Vaccines
PRESS RELEASE

published on 10/14/2024 at 07:30, 1 year 9 months ago

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers
BRIEF

published on 09/14/2024 at 09:10, 1 year 10 months ago

Transgene and BioInvent: promising results for the oncolytic virus BT-001

Cancer Transgene Oncolytic Virus BioInvent BT-001

Accesswire

Published on 07/17/2026 at 15:00, 12 hours 36 minutes ago

Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
Published on 07/17/2026 at 14:00, 13 hours 36 minutes ago

Redwood AI Announces Pricing of $3.5 Million Private Placement
Published on 07/17/2026 at 13:00, 14 hours 36 minutes ago

Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
Published on 07/17/2026 at 01:00, 1 day 2 hours ago

RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 1 day 3 hours ago

LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline

View all ACCESSWIRE

EQS Group

Published on 07/17/2026 at 20:35, 7 hours ago

Farizon Opens Global Spare Part Distribution Center to Strengthen International Aftersales Support
Published on 07/17/2026 at 18:55, 8 hours 40 minutes ago

CGTN: China vows to make AI a driver for shared prosperity amid widening AI divide
Published on 07/17/2026 at 18:45, 8 hours 50 minutes ago

NNS acquires shares in OCI
Published on 07/17/2026 at 18:32, 9 hours 3 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/17/2026 at 17:49, 9 hours 46 minutes ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Under Review

Les Echos

Published on 07/17/2026 at 18:31, 9 hours 4 minutes ago

Disclosure of transactions in own shares from July 13 to July 17, 2026
Published on 07/17/2026 at 18:00, 9 hours 36 minutes ago

Information regarding compliance with gender balance rules within the Board of Directors
Published on 07/17/2026 at 17:45, 9 hours 51 minutes ago

Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026
Published on 07/16/2026 at 18:08, 1 day 9 hours ago

Aéroports de Paris S.A - June and half-year 2026 traffic figures
Published on 07/16/2026 at 17:45, 1 day 9 hours ago

H1 2026 revenue: €6.1m (+14%)

View all LES ECHOS COMFI WIRE